ORKA

Oruka Therapeutics
ORKA

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $3.29M invested in Oruka Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

54% less call options, than puts

Call options by funds: $23K | Put options by funds: $50K

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23K
Puts
$50K
Net Calls
Net Calls Change

Top Buyers

1
+$670K
2
+$295K
3
+$185K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$131K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$129K

Top Sellers

1
-$80K
2
-$46K
3
-$45K
4
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.15M
2
$824K
3
$351K
4
$185K
5
$131K
6
$130K
7
$129K
8
$121K
9
$99K
10
$70K
11
$48K
12
$28K
13
$16K
14
$6K
15
$1K
16
–
17
–
18
–
19
–